Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Mutations in FAM105B gene may be involved in autoinflammatory diseases

Nov. 29, 2016

Actelion Pharmaceuticals describes TPHI1 inhibitors

Nov. 22, 2016

Eagle Pharmaceuticals initiates rolling NDA for Ryanodex in EHS

Nov. 14, 2016

University of California develops anti-alphavbeta1 integrin inhibitors

Sep. 28, 2016

NIH grants support work at Feinstein Institute on bioelectronic medicine and sepsis

Aug. 19, 2016

Hutchison MediPharma patents PI3K inhibitors

Aug. 18, 2016

SAMD9 mutations cause new form of syndromic adrenal hypoplasia

July 29, 2016

InflaRx raises funds in series C financing

July 25, 2016

Mutations in TRMT10C identified as a cause of mitochondrial disease

July 15, 2016

Animal model studies give insight into mechanisms of disease

June 6, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026